Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
Identifieur interne : 002C05 ( Main/Exploration ); précédent : 002C04; suivant : 002C06Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
Auteurs : Bontha V. Babu [Oman] ; Gopalan R. Babu [Inde]Source :
- Transactions of the Royal Society of Tropical Medicine and Hygiene [ 1878-3503 ] ; 2014.
Descripteurs français
- KwdFr :
- Agents de santé communautaire (enseignement et éducation), Calendrier d'administration des médicaments, Connaissances, attitudes et pratiques en santé, Diéthylcarbamazine (administration et posologie), Filaricides (administration et posologie), Filariose lymphatique (), Filariose lymphatique (épidémiologie), Humains, Inde (épidémiologie), Maladies endémiques (), Mise au point de programmes, Mise en oeuvre des programmes de santé (organisation et administration), Personnel de santé (enseignement et éducation), Services de santé communautaires (organisation et administration), Systèmes de distribution des médicaments (organisation et administration), Éducation pour la santé (), Éradication de maladie, Évaluation de programme.
- MESH :
- administration et posologie : Diéthylcarbamazine, Filaricides.
- enseignement et éducation : Agents de santé communautaire, Personnel de santé.
- organisation et administration : Mise en oeuvre des programmes de santé, Services de santé communautaires, Systèmes de distribution des médicaments.
- épidémiologie : Filariose lymphatique, Inde.
- Calendrier d'administration des médicaments, Connaissances, attitudes et pratiques en santé, Filariose lymphatique, Humains, Maladies endémiques, Mise au point de programmes, Éducation pour la santé, Éradication de maladie, Évaluation de programme.
- Wicri :
- geographic : Inde.
English descriptors
- KwdEn :
- Community Health Services (organization & administration), Community Health Workers (education), Diethylcarbamazine (administration & dosage), Disease Eradication, Drug Administration Schedule, Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Endemic Diseases (prevention & control), Filaricides (administration & dosage), Health Education (methods), Health Knowledge, Attitudes, Practice, Health Personnel (education), Health Plan Implementation (organization & administration), Humans, India (epidemiology), Medication Systems (organization & administration), Program Development, Program Evaluation.
- MESH :
- chemical , administration & dosage : Diethylcarbamazine, Filaricides.
- geographic , epidemiology : India.
- education : Community Health Workers, Health Personnel.
- epidemiology : Elephantiasis, Filarial.
- methods : Health Education.
- organization & administration : Community Health Services, Health Plan Implementation, Medication Systems.
- prevention & control : Elephantiasis, Filarial, Endemic Diseases.
- Disease Eradication, Drug Administration Schedule, Health Knowledge, Attitudes, Practice, Humans, Program Development, Program Evaluation.
Abstract
India's mass drug administration (MDA) programme to eliminate lymphatic filariasis (PELF) covers all 250 endemic districts, but compliance with treatment is not adequate for the programme to succeed in eradicating this neglected tropical disease. The objective of our study was to systematically review published studies on the coverage of and compliance with MDA under the PELF in India. We searched several databases-PubMed/Medline, Google Scholar, CINAHL/EBSCO, Web of Knowledge (including Web of Science) and OVID-and by applying selection criteria identified a total of 36 papers to include in the review. Overall MDA coverage rates varied between 48.8% and 98.8%, while compliance rates ranged from 20.8% to 93.7%. The coverage-compliance gap is large in many MDA programmes. The effective level of compliance, ≥65%, was reported in only 10 of a total of 31 MDAs (5 of 20 MDAs in rural areas and 2 of 12 MDAs in urban areas). The review has identified a gap between coverage and compliance, and potentially correctable causes of this gap. These causes need to be addressed if the Indian programme is to advance towards elimination of lymphatic filariasis.
DOI: 10.1093/trstmh/tru057
PubMed: 24728444
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001553
- to stream PubMed, to step Curation: 001553
- to stream PubMed, to step Checkpoint: 001553
- to stream Ncbi, to step Merge: 006567
- to stream Ncbi, to step Curation: 006567
- to stream Ncbi, to step Checkpoint: 006567
- to stream Main, to step Merge: 002C09
- to stream Main, to step Curation: 002C05
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.</title><author><name sortKey="Babu, Bontha V" sort="Babu, Bontha V" uniqKey="Babu B" first="Bontha V" last="Babu">Bontha V. Babu</name><affiliation wicri:level="1"><nlm:affiliation>Health Systems Research Division, Indian Council of Medical Research, New Delhi 110 029, India babubontha@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Health Systems Research Division, Indian Council of Medical Research, New Delhi 110 029</wicri:regionArea><wicri:noRegion>New Delhi 110 029</wicri:noRegion></affiliation></author><author><name sortKey="Babu, Gopalan R" sort="Babu, Gopalan R" uniqKey="Babu G" first="Gopalan R" last="Babu">Gopalan R. Babu</name><affiliation wicri:level="1"><nlm:affiliation>Kerala Unit, National Institute of Virology, Indian Council of Medical Research, Alappuzha 688 005, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Kerala Unit, National Institute of Virology, Indian Council of Medical Research, Alappuzha 688 005</wicri:regionArea><wicri:noRegion>Alappuzha 688 005</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24728444</idno><idno type="pmid">24728444</idno><idno type="doi">10.1093/trstmh/tru057</idno><idno type="wicri:Area/PubMed/Corpus">001553</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001553</idno><idno type="wicri:Area/PubMed/Curation">001553</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001553</idno><idno type="wicri:Area/PubMed/Checkpoint">001553</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001553</idno><idno type="wicri:Area/Ncbi/Merge">006567</idno><idno type="wicri:Area/Ncbi/Curation">006567</idno><idno type="wicri:Area/Ncbi/Checkpoint">006567</idno><idno type="wicri:Area/Main/Merge">002C09</idno><idno type="wicri:Area/Main/Curation">002C05</idno><idno type="wicri:Area/Main/Exploration">002C05</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.</title><author><name sortKey="Babu, Bontha V" sort="Babu, Bontha V" uniqKey="Babu B" first="Bontha V" last="Babu">Bontha V. Babu</name><affiliation wicri:level="1"><nlm:affiliation>Health Systems Research Division, Indian Council of Medical Research, New Delhi 110 029, India babubontha@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Health Systems Research Division, Indian Council of Medical Research, New Delhi 110 029</wicri:regionArea><wicri:noRegion>New Delhi 110 029</wicri:noRegion></affiliation></author><author><name sortKey="Babu, Gopalan R" sort="Babu, Gopalan R" uniqKey="Babu G" first="Gopalan R" last="Babu">Gopalan R. Babu</name><affiliation wicri:level="1"><nlm:affiliation>Kerala Unit, National Institute of Virology, Indian Council of Medical Research, Alappuzha 688 005, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Kerala Unit, National Institute of Virology, Indian Council of Medical Research, Alappuzha 688 005</wicri:regionArea><wicri:noRegion>Alappuzha 688 005</wicri:noRegion></affiliation></author></analytic><series><title level="j">Transactions of the Royal Society of Tropical Medicine and Hygiene</title><idno type="eISSN">1878-3503</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Community Health Services (organization & administration)</term><term>Community Health Workers (education)</term><term>Diethylcarbamazine (administration & dosage)</term><term>Disease Eradication</term><term>Drug Administration Schedule</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Endemic Diseases (prevention & control)</term><term>Filaricides (administration & dosage)</term><term>Health Education (methods)</term><term>Health Knowledge, Attitudes, Practice</term><term>Health Personnel (education)</term><term>Health Plan Implementation (organization & administration)</term><term>Humans</term><term>India (epidemiology)</term><term>Medication Systems (organization & administration)</term><term>Program Development</term><term>Program Evaluation</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents de santé communautaire (enseignement et éducation)</term><term>Calendrier d'administration des médicaments</term><term>Connaissances, attitudes et pratiques en santé</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Filaricides (administration et posologie)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Inde (épidémiologie)</term><term>Maladies endémiques ()</term><term>Mise au point de programmes</term><term>Mise en oeuvre des programmes de santé (organisation et administration)</term><term>Personnel de santé (enseignement et éducation)</term><term>Services de santé communautaires (organisation et administration)</term><term>Systèmes de distribution des médicaments (organisation et administration)</term><term>Éducation pour la santé ()</term><term>Éradication de maladie</term><term>Évaluation de programme</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>India</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="education" xml:lang="en"><term>Community Health Workers</term><term>Health Personnel</term></keywords><keywords scheme="MESH" qualifier="enseignement et éducation" xml:lang="fr"><term>Agents de santé communautaire</term><term>Personnel de santé</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Health Education</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Mise en oeuvre des programmes de santé</term><term>Services de santé communautaires</term><term>Systèmes de distribution des médicaments</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Community Health Services</term><term>Health Plan Implementation</term><term>Medication Systems</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Endemic Diseases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Inde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Eradication</term><term>Drug Administration Schedule</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Program Development</term><term>Program Evaluation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Calendrier d'administration des médicaments</term><term>Connaissances, attitudes et pratiques en santé</term><term>Filariose lymphatique</term><term>Humains</term><term>Maladies endémiques</term><term>Mise au point de programmes</term><term>Éducation pour la santé</term><term>Éradication de maladie</term><term>Évaluation de programme</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">India's mass drug administration (MDA) programme to eliminate lymphatic filariasis (PELF) covers all 250 endemic districts, but compliance with treatment is not adequate for the programme to succeed in eradicating this neglected tropical disease. The objective of our study was to systematically review published studies on the coverage of and compliance with MDA under the PELF in India. We searched several databases-PubMed/Medline, Google Scholar, CINAHL/EBSCO, Web of Knowledge (including Web of Science) and OVID-and by applying selection criteria identified a total of 36 papers to include in the review. Overall MDA coverage rates varied between 48.8% and 98.8%, while compliance rates ranged from 20.8% to 93.7%. The coverage-compliance gap is large in many MDA programmes. The effective level of compliance, ≥65%, was reported in only 10 of a total of 31 MDAs (5 of 20 MDAs in rural areas and 2 of 12 MDAs in urban areas). The review has identified a gap between coverage and compliance, and potentially correctable causes of this gap. These causes need to be addressed if the Indian programme is to advance towards elimination of lymphatic filariasis.</div></front></TEI><affiliations><list><country><li>Inde</li><li>Oman</li></country></list><tree><country name="Oman"><noRegion><name sortKey="Babu, Bontha V" sort="Babu, Bontha V" uniqKey="Babu B" first="Bontha V" last="Babu">Bontha V. Babu</name></noRegion></country><country name="Inde"><noRegion><name sortKey="Babu, Gopalan R" sort="Babu, Gopalan R" uniqKey="Babu G" first="Gopalan R" last="Babu">Gopalan R. Babu</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24728444
|texte= Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24728444" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |